Brokerages Set Oscar Health, Inc. (NYSE:OSCR) PT at $24.00

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average recommendation of “Moderate Buy” from the eight analysts that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $24.00.

A number of equities analysts have recently weighed in on OSCR shares. Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group started coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price for the company.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now directly owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 68,978 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at $15,906,991.87. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock worth $3,007,069 in the last quarter. 25.11% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Oscar Health by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 14,244,912 shares of the company’s stock worth $130,341,000 after acquiring an additional 116,978 shares during the period. Quantbot Technologies LP increased its stake in Oscar Health by 435.5% during the 1st quarter. Quantbot Technologies LP now owns 14,495 shares of the company’s stock worth $216,000 after buying an additional 11,788 shares during the period. Oppenheimer & Co. Inc. lifted its holdings in Oscar Health by 20.8% in the 1st quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock worth $289,000 after buying an additional 3,350 shares in the last quarter. Avalon Trust Co purchased a new position in Oscar Health in the 1st quarter valued at about $69,000. Finally, Swiss National Bank grew its stake in shares of Oscar Health by 2.4% during the first quarter. Swiss National Bank now owns 263,800 shares of the company’s stock valued at $3,923,000 after acquiring an additional 6,100 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $16.82 on Tuesday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The stock has a market cap of $4.07 billion, a price-to-earnings ratio of -129.38, a PEG ratio of 32.07 and a beta of 1.62. The company’s 50-day moving average price is $18.74 and its 200 day moving average price is $18.36. Oscar Health has a 52 week low of $4.84 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The business had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.13 billion. During the same period last year, the company posted ($0.07) EPS. The company’s revenue was up 44.6% on a year-over-year basis. As a group, research analysts forecast that Oscar Health will post 0.01 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.